Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;71(4):578-587.
doi: 10.1007/s12026-023-09375-3. Epub 2023 Mar 29.

Autoinflammatory diseases and the kidney

Affiliations
Review

Autoinflammatory diseases and the kidney

Mohamed Tharwat Hegazy et al. Immunol Res. 2023 Aug.

Abstract

The kidney represents an important target of systemic inflammation. Its involvement in monogenic and multifactorial autoinflammatory diseases (AIDs) vary from peculiar and relatively frequent manifestations to some rare but severe features that may end up requiring transplantation. The pathogenetic background is also very heterogeneous ranging from amyloidosis to non-amyloid related damage rooted in inflammasome activation. Kidney involvement in monogenic and polygenic AIDs may present as renal amyloidosis, IgA nephropathy, and more rarely as various forms of glomerulonephritis (GN), namely segmental glomerulosclerosis, collapsing glomerulopathy, fibrillar, or membranoproliferative GN. Vascular disorders such as thrombosis or renal aneurysms and pseudoaneurysms may be encountered in patients with Behcet's disease. Patients with AIDs should be routinely assessed for renal involvement. Screening with urinalysis, serum creatinine, 24-h urinary protein, microhematuria, and imaging studies should be carried out for early diagnosis. Awareness of drug-induced nephrotoxicity, drug-drug interactions as well as addressing the issue of proper renal adjustment of drug doses deserve a special mention and should always be considered when dealing with patients affected by AIDs. Finally, we will explore the role of IL-1 inhibitors in AIDs patients with renal involvement. Targeting IL-1 may indeed have the potential to successfully manage kidney disease and improve long-term prognosis of AIDs patients.

Keywords: Amyloidosis; Autoinflammatory diseases (AIDs); Drug-induced nephrotoxicity; Inflammasome; Interleukin-1 inhibitors; Kidney involvement; Nephropathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
(A: H&E – ×400): 55 years male patient with FMF. A glomerulus shows abundant mesangial as well as capillary wall deposits of amorphous eosinophilic material. (B: PAS-×400): The deposited material is PAS negative. (C: Congo red-×400): Congo red stain reveals organophilic glomerular deposits; with polarized light an apple green birefringence is seen. (D: Immunoperoxidase, AA protein-x400): The tufts are strongly positive for amyloid associated protein (Courtesy of Dr. Wael M. Hamza, Department of Pathology, Cairo University)
Fig. 2
Fig. 2
(A: H&E – ×400): 38 years male patient with FMF. A glomerulus shows mesangial hypercellularity and hypertrophied epithelial cells. Increased intraluminal leukocytes and congestion are also evident. (B: IF, IgA-×400): The immunofluorescence study reveals dominant mesangial deposits for IgA. (C &D: IF, C3 & IgG-×400): Subtle deposits of C3 (image C), while IgG was negative (image D). (Courtesy of Dr. Wael M. Hamza, Department of Pathology, Cairo University)
Fig. 3
Fig. 3
(A: H&E & B: JMS – ×400): 32 years female patient with FMF. Two glomeruli show compressed tufts by cellular crescents. (C & D: IF-×400): Immunofluorescence study reveals positive glomerular deposits for IgG (image C) and IgM (image D). (Courtesy of Dr. Wael M. Hamza, Department of Pathology, Cairo University)

References

    1. Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol. 2020;146(5):925–937. doi: 10.1016/j.jaci.2020.08.017. - DOI - PMC - PubMed
    1. Lucherini OM, et al. Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases. Clin Exp Rheumatol. 2018;36(Suppl 110(1)):3–9. - PubMed
    1. Navallas M, et al. Autoinflammatory diseases in childhood, part 1: monogenic syndromes. Pediatr Radiol. 2020;50(3):415–430. doi: 10.1007/s00247-019-04536-9. - DOI - PubMed
    1. Gaggiano C, et al. Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases. Mediators Inflamm. 2019;2019:3293145. doi: 10.1155/2019/3293145. - DOI - PMC - PubMed
    1. Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol. 2011;22(6):1007–1018. doi: 10.1681/ASN.2010080798. - DOI - PubMed

Publication types

MeSH terms